s1 May 1969An Immunologic Test for Prognosis in Advanced Hodgkin's Disease.Joseph E. Sokal, M.D., F.A.C.P., C. William Aungst, M.D.Joseph E. Sokal, M.D., F.A.C.P.Search for more papers by this author, C. William Aungst, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-70-5-1106_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPrognosis in Hodgkin's disease is notoriously difficult. Some patients die rapidly despite early and aggressive therapy, while others with various combinations of unfavorable prognostic signs live for very many years. This variability is attributed to differences in "host resistance." The intimate relationship of defects in cellular immune mechanisms with the course of Hodgkin's disease led us to the hypothesis that host resistance in this disease is directly related to the integrity of these mechanisms. If so, assessment of cellular immune capacity should have significant prognostic value. To test this, 32 tuberculin-negative patients with advanced Hodgkin's disease (stage III, 9; stage... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Buffalo, New York PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 May 1969Volume 70, Issue 5Page: 1106-1107KeywordsHodgkin lymphoma Issue Published: 1 May 1969 PDF DownloadLoading ...